News & Updates
Filter by Specialty:
Post-COVID-19 vax uveitis may be more common in Southeast Asia
COVID-19 vaccination-induced uveitis is uncommon, with cases mostly self-limiting and showing good responses to treatment with no long-term sequelae, according to a Singapore study. However, reactivation of such infections appears to occur at a higher proportion in Southeast Asia, where viral and toxoplasma infections are more common.
Post-COVID-19 vax uveitis may be more common in Southeast Asia
25 Jul 2022
Obese/overweight patients incur 10 percent long-term weight loss with lifestyle management, medication
Individuals who are overweight or obese can achieve an approximately 10 percent weight loss over 3–5 years with the use of anti-obesity medications in addition to lifestyle management, according to a retrospective study presented at ENDO 2022.
Obese/overweight patients incur 10 percent long-term weight loss with lifestyle management, medication
25 Jul 2022
Secondary analysis boosts potential of atogepant for migraine prophylaxis in adults
In the secondary analysis of the phase III ADVANCE trial, responder rates were markedly higher with atogepant irrespective of dose than with placebo in adults with migraine.
